Clinical Trial Update: A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C [Phase 1]

View source ↗

Summary

Clinical trial update reports a Phase 1 multiple ascending dose study of GS-5885 in treatment-naive subjects with genotype 1 chronic hepatitis C. The study, spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GS-5885 (GS-5885)

Snippet

Sponsor: Gilead Sciences | Conditions: HCV Infection | Phase 1 | Status: COMPLETED